Max Healthcare Institute Allots 57,461 Equity Shares Under Employee Stock Option Scheme 2022

1 min read     Updated on 01 Apr 2026, 10:17 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Max Healthcare Institute Limited allotted 57,461 equity shares under its Employee Stock Option Scheme 2022 on April 1, 2026, following NRC approval. The shares were issued at ₹350 per share with ₹340 premium to employees exercising vested options. This increased the company's total equity shares to 97,31,92,502 and paid-up capital to ₹973,19,25,020, with no lock-in restrictions on the newly allotted shares.

powered bylight_fuzz_icon
36564422

*this image is generated using AI for illustrative purposes only.

Max Healthcare Institute Limited has announced the allotment of 57,461 equity shares to eligible employees under its Employee Stock Option Scheme 2022. The company's Nomination & Remuneration Committee approved this allotment on April 1, 2026, at 9:06 am IST, following the exercise of vested stock options by employees.

Share Allotment Details

The allotted equity shares carry a face value of ₹10 each and are fully paid-up. Employees exercised their stock options at ₹350 per equity share, with a premium of ₹340 per share. The shares have been issued in dematerialized form and are identical to existing equity shares in all respects.

Impact on Share Capital

The allotment has resulted in an increase in the company's equity share capital structure:

Particulars Pre-allotment Post-allotment
No. of Equity Shares 97,31,35,041 97,31,92,502
Face Value ₹10 ₹10
Paid-up Equity Capital ₹973,13,50,410 ₹973,19,25,020

The newly allotted shares have distinctive numbers ranging from 97,31,35,042 to 97,31,92,502 (both inclusive) and carry the ISIN number INE027H01010.

Regulatory Compliance

Max Healthcare Institute Limited has filed the requisite details with both BSE Limited and National Stock Exchange of India Limited in accordance with regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company had initially filed the ESOP statement on September 29, 2022, with filing numbers DCS/IPO/MJ/ESOP-IP/2511/2022-23 for BSE and NSE/LIST/32765 for NSE.

Key Features

The allotment carries several important characteristics:

  • No lock-in period applicable on the allotted shares
  • Shares are immediately tradeable and identical to existing equity shares
  • No additional listing fees payable for this allotment
  • Allotment classified as non-material under SEBI regulations

The company has disclosed that this allotment is not considered material in nature under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure has been made available on the company's website at www.maxhealthcare.in for public access.

Historical Stock Returns for Max Healthcare Institute

1 Day5 Days1 Month6 Months1 Year5 Years
-2.39%-5.29%-14.29%-15.92%-13.63%+328.94%

How might this ESOP allotment impact Max Healthcare's employee retention and talent acquisition strategy in the competitive healthcare sector?

What percentage of the total ESOP pool has now been utilized, and how many more tranches are expected in the coming quarters?

Could this employee stock allocation signal Max Healthcare's preparation for major expansion or acquisition activities requiring motivated staff?

Max Healthcare Institute
View Company Insights
View All News
like18
dislike

Max Healthcare's Subsidiary ET Planners Private Limited Dissolved Following NCLT Order

2 min read     Updated on 26 Mar 2026, 02:47 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Max Healthcare Institute Limited has completed the voluntary liquidation of its step-down subsidiary ET Planners Private Limited following an NCLT order on March 25, 2026. The liquidation process, initiated in September 2024, involved transferring the entire business undertaking worth Rs. 41,72,45,487 in creditor claims to Alps Hospital Limited on a going concern basis. The company has confirmed no material impact on its financials or business operations from this dissolution.

powered bylight_fuzz_icon
36019023

*this image is generated using AI for illustrative purposes only.

Max Healthcare Institute Limited has announced the successful completion of the voluntary liquidation process for its step-down subsidiary ET Planners Private Limited, following an order passed by the National Company Law Tribunal (NCLT) on March 25, 2026. The healthcare major received the NCLT order on March 25, 2026, at 6:00 pm IST, formally dissolving the subsidiary.

Liquidation Process Timeline

The voluntary liquidation process for ET Planners Private Limited commenced in September 2024, with the company providing multiple intimations to stock exchanges regarding the proceedings. The process began with a board resolution on September 6, 2024, followed by an extraordinary general meeting on September 11, 2024, where shareholders passed a special resolution to initiate voluntary liquidation proceedings.

Key Milestone Date Details
Board Resolution September 6, 2024 Approved voluntary liquidation
EGM & Special Resolution September 11, 2024 Liquidation commencement date
Public Announcement September 13, 2024 Claims submission notice
Claims Deadline October 10, 2024 Final date for creditor claims
NCLT Order March 25, 2026 Company dissolution

Company Structure and Financial Details

ET Planners Private Limited was incorporated on September 26, 2017, under the Companies Act, 2013, with CIN U74999DL2017PTC324142. The company operated as a step-down wholly-owned subsidiary of Max Healthcare through Alps Hospital Limited.

Financial Parameter Amount
Authorized Share Capital Rs. 1,00,00,000
Paid-up Share Capital Rs. 1,16,620
Equity Shares 11,662 shares of Rs. 10 each
Creditor Claims Rs. 41,72,45,487

Business Transfer and Impact

The entire business undertaking of ET Planners, comprising all assets, liabilities, customer and supplier contracts, service agreements, leases, licenses, and employees, has been transferred to Alps Hospital Limited on a going concern basis. All creditors amounting to Rs. 41,72,45,487 provided their no-objection certificates for the transfer of claims as part of the business distribution.

Max Healthcare has emphasized that the liquidation will not affect any business or accounting policies and will not have any material impact on the company's financials. The company was originally established to manage and support hospitals, diagnostic centers, clinics, and other healthcare institutions across India.

Regulatory Compliance

The liquidation process was conducted under Section 59 of the Insolvency & Bankruptcy Code, 2016, with Ms. Sunita Umesh appointed as the liquidator. The process included:

  • Declaration of solvency by directors filed on September 24, 2024
  • Public announcement in Financial Express and Jansatta newspapers
  • Compliance with IBBI regulations throughout the process
  • No-objection certificates from regulatory authorities including Income Tax Department

NCLT Order Details

The NCLT New Delhi Bench Court-VI, comprising Justice Jyotsna Sharma and Ms. Anu Jagmohan Singh, passed the dissolution order after reviewing all compliance requirements. The tribunal noted that no adverse comments were received from statutory authorities or the public despite the public announcement and IBBI website updates.

The liquidator has been directed to preserve physical or electronic copies of all reports, registers, and documents for eight years (electronic) and three years (physical) after dissolution. The order also allows tax authorities to assess and recover any dues arising from the business transfer in accordance with applicable law.

Historical Stock Returns for Max Healthcare Institute

1 Day5 Days1 Month6 Months1 Year5 Years
-2.39%-5.29%-14.29%-15.92%-13.63%+328.94%

Will Max Healthcare pursue similar subsidiary consolidations to streamline its corporate structure and reduce compliance costs?

How might the successful transfer of Rs. 41+ crore in creditor claims to Alps Hospital Limited impact Max Healthcare's debt servicing capabilities?

Could this liquidation signal Max Healthcare's strategic shift towards focusing on core hospital operations rather than diversified healthcare services?

Max Healthcare Institute
View Company Insights
View All News
like17
dislike

More News on Max Healthcare Institute

1 Year Returns:-13.63%